SCHEMBL8717597

SCHEMBL8717597

CSc1c(C=O)c2ccccc2n1Cc1ccccc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 5/20 0.54
▸ ALDH1A1 P00352 4/20 0.53
▸ NPSR1 Q6W5P4 3/20 0.53
▸ MEN1 O00255 3/20 0.52
▸ KMT2A Q03164 3/20 0.52
▸ POLB P06746 2/20 0.52
▸ KDM4E B2RXH2 1/20 0.52
▸ USP2 O75604 1/20 0.52
▸ CYP19A1 P11511 1/20 0.51
▸ PSMD14 O00487 1/20 0.50
▸ P2RX4 Q99571 1/20 0.50
▸ SMN1; SMN2 Q16637 3/20 0.47
▸ MAPK1 P28482 1/20 0.47
▸ PLA2G2A P14555 1/20 0.46
▸ TSHR P16473 1/20 0.46
▸ ATM Q13315 1/20 0.45
▸ MAPT P10636 1/20 0.45
▸ HTT P42858 1/20 0.45
▸ NOD2 Q9HC29 1/20 0.45
▸ THRB P10828 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10624841 0.81 LMNA (0.79) LMNAALDH1A1NPSR1MEN1KMT2A
SCHEMBL2345535 0.79 KMT2A (0.60) LMNAALDH1A1NPSR1MEN1KMT2A
SCHEMBL28216521 0.79 CYP19A1 (0.58) LMNAALDH1A1NPSR1MEN1KMT2A
SCHEMBL8715099 0.78 MAPT (0.43) LMNAALDH1A1NPSR1MEN1KMT2A
SCHEMBL336895 0.77 LMNA (0.54) LMNAALDH1A1NPSR1MEN1KMT2A
SCHEMBL2860366 0.77 LMNA (0.59) LMNAALDH1A1NPSR1MEN1KMT2A
SCHEMBL5851288 0.76 LMNA (0.53) LMNAALDH1A1NPSR1MEN1KMT2A
SCHEMBL29952318 0.75 KMT2A (0.85) LMNAALDH1A1NPSR1MEN1KMT2A
SCHEMBL10493566 0.74 LMNA (0.54) LMNAALDH1A1NPSR1MEN1KMT2A
SCHEMBL9255854 0.71 MEN1 (0.60) LMNAALDH1A1NPSR1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5783575-A CENTRAL NERVOUS SYSTEM DISORDERS NOVO NORDISK A/S (DK) 1998-07-21 — — US disclosed
EP-0843660-A1 HETEROCYCLIC COMPOUNDS, THEIR PREPARATION AND USE NOVO NORDISK A/S (DK) 1998-05-27 — — EP disclosed
US-5696148-A POTENT ANTAGONIST OF METABOTROPIC GLUTAMATE RECEPTORS; TREATING EPILEPSY, PARKINSON'S DISEASE, HUNTINGTON'S DISEASE, BRAIN DISORDER AND ALZHEIMER'S DISEASE NOVO NORDISK A/S (DK) 1997-12-09 — — US disclosed
WO-1997005109-A1 HETEROCYCLIC COMPOUNDS, THEIR PREPARATION AND USE NOVO NORDISK A/S (DK) 1997-02-13 — — WO disclosed
Send feedback